Bio-Rad Laboratories BIO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Clinical Diagnostics | $1.57B+0.4% | $1.56B+2.1% | $1.53B+0.2% | $1.53B+0.1% | $1.53B-0.8% | |
| Life Science | $1.02B0.0% | $1.02B-0.7% | $1.03B+0.1% | $1.03B+1.2% | $1.02B-1.3% | |
| Net Sales by Geography | ||||||
| Americas | $170.7M+3.2% | $165.4M+2.1% | $162M-0.7% | $163.1M-3.3% | $168.6M-0.4% | |
| Asia Pacific | $519.6M+1.2% | $513.3M+3.1% | $497.9M-1.2% | $503.8M-0.9% | $508.6M-2.5% | |
| Europe | $888.8M+0.8% | $881.8M+2.4% | $860.9M+2.0% | $844.4M+1.3% | $833.7M0.0% | |
| UNITED STATES | $1.01B-1.2% | $1.02B-1.4% | $1.04B-0.6% | $1.04B+1.2% | $1.03B-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Rad Laboratories break its business down?
- Bio-Rad Laboratories (BIO) reports net sales by business across 3 parts — All Other Segments, Clinical Diagnostics and Life Science. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Rad Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Rad Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
